supp.ai
Discover Supplement-Drug Interactions
Disclaimer: The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The tool is not a substitute for the care provided… (more)
Last Updated: 3 years ago
supplement:
Iron, Dietary
Research Papers that Mention the Interaction
“The iron chelator deferoxamine mesylate DFO ) decreased the iron content in the bone, liver, and spleen, and significantly relieved unloading‐induced bone loss under HyMF reloading.”
Disorder of Iron Metabolism Inhibits the Recovery of Unloading‐Induced Bone Loss in Hypomagnetic Field“The iron chelator deferoxamine mesylate DFO ) reduced the iron content in bone and alleviated unloading-induced bone loss.”
“However, as shown earlier with IRP1, both desferrioxamine mesylate and succinyl acetone will inhibit the degradation of IRP2 induced by iron but not that induced by heme.”
“Studies have shown that the degradation of IRP1 that is induced by iron can be inhibited by either desferrioxamine mesylate (an iron chelator) or succinyl acetone (an inhibitor of heme synthesis), whereas the degradation induced by heme cannot.”
Help us improve supp.ai, we'd love to hear your feedback: Submit Feedback